Research Nester released a report titled “Organoids Market: Global Demand Analysis & Opportunity Outlook 2027” which delivers detailed overview of the global organoids market in terms of market segmentation by product, by application and by region.

Further, for the in-depth analysis, the report encompasses the industry growth drivers, restraints, supply and demand risk, market attractiveness, BPS analysis and Porter’s five force model.

Organoids are three-dimensional tissues that are similar in structure and function to the human organs. This allows researchers to work and conduct clinical trials in a more accurate manner, thereby enhancing the therapeutic products. The market for organoids is anticipated to record a significantly high CAGR during the forecast period, i.e., 2019-2027. The market is segmented by product, by application and by region, out of which, the product segment is further segmented into intestinal organoid, neural organoid, hepatic organoid, pancreatic organoid and others. The demand for the various types of organoids is predicted to grow on account of rising cases of cancers and other disorders which require research. However, the demand for neural and intestinal organoids is estimated to increase at the highest rate, thereby raising the segment growth in the upcoming years.

Based on geography, the organoids market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. The market in Europe is anticipated to observe a lucrative growth as a result of growing research activities and technological advances in the medical industry in European countries such as Germany and the United Kingdom. Organoids market in North America is estimated to grow significantly on the back of growing expenditure in the healthcare industry by various organizations and institutions in order to promote research, especially in the United States.

Rising Demand for 3D Cell Culture Technology to Raise the Market Growth

The growing demand for 3D cell cultures and organoids at research labs and institutions is anticipated to increase the growth of organoids market significantly in future. This can be attributed to the usage of organoids for clinical testing and development of medicinal products. However, the lack of skilled researchers involved in the study of organoids is predicted to be a major growth restricting factor for the market.

This report also provides the existing competitive scenario of some of the key players of the global organoids market which includes company profiling of Hubrecht Organoid Technology (HUB), DefiniGEN, Cellesce Ltd, QGel SA, OcellO B.V., Trevigen Inc., Corning Incorporated (NYSE: GLW), STEMCELL Technologies Inc., Path Bioanalytics and Merck KGaA (ETR: MRK). The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the global organoids market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.